Shervin Alborzian - Related publications

Boston University, Boston, MA, United States 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
23 most relevant papers in past 60 days:
Year Citation  Score
2022 Wang Y, Liu X, Peng D, Wu Y, Su Y, Xu J, Ma X, Li Y, Shi J, Cheng X, Rong H, Fang Y. A Preliminary Study of Different Treatment Strategies for Anxious Depression. Neuropsychiatric Disease and Treatment. 18: 11-18. PMID 35018097 DOI: 10.2147/NDT.S320091   
2022 Mirman AM, Corlier J, Wilson AC, Tadayonnejad R, Marder KG, Pleman CM, Krantz DE, Wilke SA, Levitt JG, Ginder ND, Ojha R, Daskalakis ZJ, Leuchter AF, Lee JC. Absence of early mood improvement as a robust predictor of rTMS nonresponse in major depressive disorder. Depression and Anxiety. PMID 34990046 DOI: 10.1002/da.23237   
2022 Kim M, Choi EJ, Kwon OJ, Park HJ, Kim AR, Seo BN, Chung SY, Lee JH, Kim JH. Electroacupuncture plus moxibustion for major depressive disorder: A randomized, sham-controlled, pilot clinical trial. Integrative Medicine Research. 11: 100802. PMID 34840949 DOI: 10.1016/j.imr.2021.100802   
2022 Coussement C, Heeren A. Sleep problems as a transdiagnostic hub bridging impaired attention control, generalized anxiety, and depression. Journal of Affective Disorders. 296: 305-308. PMID 34606807 DOI: 10.1016/j.jad.2021.09.092   
2022 Fugger G, Bartova L, Fabbri C, Fanelli G, Dold M, Swoboda MMM, Kautzky A, Zohar J, Souery D, Mendlewicz J, Montgomery S, Rujescu D, Serretti A, Kasper S. The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries. European Archives of Psychiatry and Clinical Neuroscience. PMID 34989830 DOI: 10.1007/s00406-021-01368-3   
2022 Yilmaz S, Huguet A, Kisely S, Rao S, Wang J, Baur K, Price M, O'Mahen H, Wright K. Do psychological interventions reduce symptoms of depression for patients with Bipolar I or II Disorder? A meta-analysis. Journal of Affective Disorders. PMID 35007645 DOI: 10.1016/j.jad.2021.12.112   
2022 Jadnanansing R, de Beurs E, Etwaroo K, Blankers M, Dwarkasing R, Peen J, Lumsden V, Bipat R, Dekker J. A survey of depression and anxiety disorders in urban and rural Suriname. Bmc Public Health. 22: 51. PMID 34998381 DOI: 10.1186/s12889-021-12454-5   
2022 Zhao H, Jin K, Jiang C, Pan F, Wu J, Luan H, Zhao Z, Chen J, Mou T, Wang Z, Lu J, Lu S, Hu S, Xu Y, Huang M. A pilot exploration of multi-omics research of gut microbiome in major depressive disorders. Translational Psychiatry. 12: 8. PMID 35013099 DOI: 10.1038/s41398-021-01769-x   
2022 Piccirillo ML, Rodebaugh TL. Personalized networks of social anxiety disorder and depression and implications for treatment. Journal of Affective Disorders. 298: 262-276. PMID 34699851 DOI: 10.1016/j.jad.2021.10.034   
2022 Godfrey KEM, Muthukumaraswamy SD, Stinear CM, Hoeh N. Decreased salience network fMRI functional connectivity following a course of rTMS for treatment-resistant depression. Journal of Affective Disorders. 300: 235-242. PMID 34986371 DOI: 10.1016/j.jad.2021.12.129   
2022 Peng Y, Knotts JD, Young KS, Bookheimer SY, Nusslock R, Zinbarg RE, Kelley NJ, Echiverri-Cohen AM, Craske MG. Threat Neurocircuitry Predicts the Development of Anxiety and Depression Symptoms in a Longitudinal Study. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 35031524 DOI: 10.1016/j.bpsc.2021.12.013   
2022 Worrall H, Miller S, Cullum M, Chung J. Impact of Psychological Disorders on Clinical Presentation of Pediatric Patients Following a Concussion. Neurology. 98: S21. PMID 34969923 DOI: 10.1212/01.wnl.0000801932.81288.94   
2022 Moccia L, Lanzotti P, Pepe M, Palumbo L, Janiri D, Camardese G, Bentivoglio AR, Di Nicola M, Calabresi P, Sani G. Remission of functional motor symptoms following esketamine administration in a patient with treatment-resistant depression: a single-case report. International Clinical Psychopharmacology. 37: 21-24. PMID 34825899 DOI: 10.1097/YIC.0000000000000378   
2022 Zhao Y, Dahmani L, Li M, Hu Y, Ren J, Lui S, Wang D, Kuang W, Gong Q, Liu H. Individualized functional connectome identified replicable biomarkers for dysphoric symptoms in first-episode medication-naïve patients with major depressive disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 34995770 DOI: 10.1016/j.bpsc.2021.12.010   
2022 Miola A, Dal Porto V, Meda N, Perini G, Solmi M, Sambataro F. Secondary Mania induced by TNF-α inhibitors: A systematic review. Psychiatry and Clinical Neurosciences. 76: 15-21. PMID 34590391 DOI: 10.1111/pcn.13302   
2022 Fugger G, Bartova L, Dold M, Fabbri C, Fanelli G, Zanardi R, Kautzky A, Zohar J, Souery D, Mendlewicz J, Montgomery S, Rujescu D, Serretti A, Kasper S. Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 114: 110480. PMID 34826558 DOI: 10.1016/j.pnpbp.2021.110480   
2022 Hen-Shoval D, Weller A, Weizman A, Shoval G. Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review. International Journal of Environmental Research and Public Health. 19. PMID 35010782 DOI: 10.3390/ijerph19010523   
2022 Bekhbat M, Treadway MT, Felger JC. Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications. Current Topics in Behavioral Neurosciences. PMID 34971449 DOI: 10.1007/7854_2021_294   
2022 Magnotta VA, Xu J, Fiedorowicz JG, Williams A, Shaffer J, Christensen G, Long JD, Taylor E, Sathyaputri L, Richards JG, Harmata G, Wemmie J. Metabolic Abnormalities in the Basal Ganglia and Cerebellum in Bipolar Disorder: A Multi-modal MR Study. Journal of Affective Disorders. PMID 35031333 DOI: 10.1016/j.jad.2022.01.052   
2022 Heerlein K, De Giorgi S, Degraeve G, Frodl T, Hagedoorn W, Oliveira-Maia AJ, Otte C, Perez Sola V, Rathod S, Rosso G, Sierra P, Vita A, Morrens J, Rive B, Mulhern Haughey S, et al. Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilization. Journal of Affective Disorders. 298: 442-450. PMID 34742998 DOI: 10.1016/j.jad.2021.11.004   
2022 Berger M, Kermer J, Behr J, Schulz-Menger J, Bilal S, Osterland SL, O'Malley G, Bschor T, Schlattmann P, Stamm T, Steinacher B, de Millas W, Richter C, Heinz A, Adli M, et al. Electrocardiographic Changes During Initiation of Lithium Augmentation of Antidepressant Pharmacotherapy. Journal of Clinical Psychopharmacology. 42: 87-91. PMID 34854829 DOI: 10.1097/JCP.0000000000001496   
2022 Fellinger M, Waldhör T, Serretti A, Hinterbuchinger B, Pruckner N, König D, Gmeiner A, Vyssoki S, Vyssoki B, Fugger G. Seasonality in Major Depressive Disorder: Effect of Sex and Age. Journal of Affective Disorders. 296: 111-116. PMID 34600171 DOI: 10.1016/j.jad.2021.09.051   
2022 Paul ER, Schwieler L, Erhardt S, Boda S, Trepci A, Kämpe R, Asratian A, Holm L, Yngve A, Dantzer R, Heilig M, Hamilton JP, Samuelsson M. Peripheral and central kynurenine pathway abnormalities in major depression. Brain, Behavior, and Immunity. 101: 136-145. PMID 34999196 DOI: 10.1016/j.bbi.2022.01.002